Oak Thistle LLC’s Edwards Lifesciences EW Stock Holding History

Oak Thistle LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.48M	Buy	+28,750	New	+$2.56M	0.23%	167
2026 Q2	–	Sell	-37,529	Closed	-$3.01M	–	527
2026 Q1	$3.01M	Buy	+37,529	New	+$3.09M	0.29%	118
2024 Q4	–	Sell	-30,245	Closed	-$2M	–	447
2024 Q3	$2M	Buy	+30,245	New	+$2.2M	0.65%	18
2023 Q4	–	Sell	-10,100	Closed	-$700K	–	507
2023 Q3	$700K	Buy	+10,100	New	+$812K	0.21%	212
2023 Q2	–	Sell	-8,121	Closed	-$672K	–	414
2023 Q1	$672K	Buy	+8,121	New	+$638K	0.4%	71
2022 Q2	–	Sell	-7,749	Closed	-$912K	–	257
2022 Q1	$912K	Buy	+7,749	New	+$869K	0.48%	40

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Oak Thistle LLC's EW Position: Q3 2026 in Review

Oak Thistle LLC opened a new position in Edwards Lifesciences (EW) in Q3 2026: 28,750 shares worth $2.48M. The stake represents 0.23% of the portfolio and ranks #167 among its holdings. This is a return to the name: Oak Thistle LLC previously reported a position in EW as recently as Q1 2026.

Oak Thistle LLC first reported a position in EW in Q1 2022 and has held it in 6 quarters since. The position peaked at $3.01M in Q1 2026. 285 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Oak Thistle LLC held 28,750 shares of Edwards Lifesciences worth $2.48M as of Q3 2026.
Edwards Lifesciences was a new Oak Thistle LLC position in Q3 2026.
Edwards Lifesciences made up 0.23% of Oak Thistle LLC's portfolio in Q3 2026, its #167 holding.
Oak Thistle LLC first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 6 quarters since.
Oak Thistle LLC's Edwards Lifesciences position peaked at $3.01M in Q1 2026.
285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Oak Thistle LLC's 13F filing for Q3 2026, filed 21 Oct 2026.